This randomized, double-blind, placebo-controlled trial published in the International Journal of Dermatology (1993, PMID: 8225725) evaluated the safety and effectiveness of 2% topical minoxidil in 256 women aged 18 to 45 with androgenetic alopecia. Over 32 weeks, participants applied 1 mL of solution twice daily. Results showed a statistically significant
